Myositis Specific Autoantibodies: A Clinical Perspective

Figures & data

Table 1 Summarize the Myositis Specific Auto Antibodies and Their Clinical Perspective

Antibodies	Characteristic Clinical Spectrum
Anti-Mi-2 Antibodies	Cutaneous symptoms
	Good response to treatments
	Less susceptible to ILD or cancer
Anti-SAE Antibodies	Cutaneous manifestations
	Dysphagia
Anti-MDA5 Antibodies	Cutaneous manifestations
	ILD Risk
Anti-NXP-2 Antibodies	Calcinosis
	Malignancy Risk
Anti-TIF1-Gamma Antibodies	Malignancy Risk
Anti-ARS Antibodies	Types:
	Jo-1
	PL-7
	PL-12
	OJ
	EJ
	KS
	Ha
	Zo